India's Serum Institute asks SA to approve its COVID-19 vaccine

India's largest vaccine manufacturer Serum Institute of India has sought emergency use approval from the South African drug regulator for its COVID-19 vaccine. Covovax is a licensed version of the Novavax vaccine and is being mass-manufactured in India. Health experts, there are calling it a promising booster, as Ishan Garg reports from New Delhi. For more news, visit sabcnews.com and also #SABCNews #Coronavirus #COVID19News #Covid-19Vaccination #Vaccine on Social Media.